scholarly article | Q13442814 |
P50 | author | Iveta Herichova | Q56027684 |
Michal Zeman | Q64496624 | ||
P2093 | author name string | Bada V | |
Dulková K | |||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
melatonin | Q180912 | ||
P1104 | number of pages | 9 | |
P304 | page(s) | 1795-1803 | |
P577 | publication date | 2005-01-20 | |
P1433 | published in | Life Sciences | Q5256275 |
P1476 | title | Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile | |
P478 | volume | 76 |
Q38053166 | Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation |
Q48132649 | Altered Circadian Timing System-Mediated Non-Dipping Pattern of Blood Pressure and Associated Cardiovascular Disorders in Metabolic and Kidney Diseases |
Q38037124 | Cardiovascular effects of melatonin receptor agonists |
Q37293950 | Causes and mechanisms of nondipping hypertension |
Q38045905 | Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. |
Q57164131 | Diurnal blood pressure changes |
Q46099814 | Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats |
Q22305847 | Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials |
Q45849271 | Effects of living at two ambient temperatures on 24-h blood pressure and neuroendocrine function among obese and non-obese humans: a pilot study |
Q89459072 | Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review |
Q36041575 | Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review |
Q33930296 | Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin. |
Q38906296 | Melatonin and Human Cardiovascular Disease. |
Q36793940 | Melatonin as a potential antihypertensive treatment |
Q47929503 | Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias. |
Q43252110 | Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability |
Q50669397 | Melatonin secretion is impaired in women with preeclampsia and an abnormal circadian blood pressure rhythm. |
Q42783953 | Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. |
Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
Q48183958 | Nocturnal urinary melatonin excretion is associated with non-dipper pattern in elderly hypertensives |
Q34486692 | Peripheral and central effects of melatonin on blood pressure regulation |
Q87922988 | Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort |
Q34247221 | The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension |
Q91063407 | The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials |
Q37808650 | The physiological roles of phosducin: from retinal function to stress-dependent hypertension |
Q54363570 | The presence and localization of melatonin receptors in the rat aorta. |
Q34358480 | Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders |
Q47808897 | Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe |
Search more.